Health - Google News: Biogen Hemophilia A Therapy Helps in Fewer Injections - Businessweek

Health - Google News Google News

Biogen Hemophilia A Therapy Helps in Fewer Injections - Businessweek Oct 31st 2012, 15:00 Mass High Tech Biogen Hemophilia A Therapy Helps in Fewer Injections Businessweek Biogen Idec Inc. (BIIB) and partner Swedish Orphan Biovitrum AB (SOBI) said their hemophilia A therapy controlled bleeding with fewer injections in a late-stage study. The companies plan to apply for U.S. approval early next year. The therapy, long-lasting ... Biogen gives positive data on hemophilia candidateMass High Tech Biogen sees positive results from drug studyBoston Herald Biogen streak lives on with upbeat PhIII results for hemophilia A therapyFierceBiotech Investor's Business Daily -NASDAQ all 46 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: